CMS Blocks Medicaid Funding for Pediatric Gender Treatments as Fraud Crackdown Widens, RFK Jr. Faces New Credibility Questions

The Trump administration announced that the Centers for Medicare and Medicaid Services will no longer allow Medicaid or Children's Health Insurance Program (CHIP) dollars to pay for puberty blockers, cross-sex hormones, or surgeries marketed as gender-transition care for minors, according to Breitbart News. The announcement came from HHS under Secretary Robert F. Kennedy Jr. and CMS Administrator Dr. Mehmet Oz.

A Department of Health and Human Services report cited by Breitbart alleges that hospitals used false diagnostic codes to bill insurers for puberty blockers and other drugs given to minors seeking to transition. HHS has not publicly named which hospitals or systems are implicated, and no criminal charges tied specifically to that report have been announced.

The fraud crackdown is bigger than one policy

The gender-care funding cutoff is part of a broader Medicaid fraud push. HHS Secretary Kennedy said the administration is deferring more than $1 billion in Medicaid payments to California and Minnesota over claims his department flagged as high-risk, according to Breitbart.

Separately, Minnesota Attorney General Keith Ellison's Medicaid Fraud Control Unit charged Salman Ahmed Elmi, a state-honored Outstanding Refugee award recipient, with eight felony theft counts over more than $1 million in allegedly fraudulent Medicaid billing. Those are charges, not a conviction, and Elmi has not been reported as having entered a plea in available reporting.

House Budget Committee Chairman Jodey Arrington (R-TX) told Breitbart News that fraud across federal health programs has reached crisis levels and is pushing legislation that would direct $28 billion toward Medicare and Medicaid fraud enforcement, including more investigators and modern detection technology.

The case against the ban

Medical associations that support youth gender-transition protocols, including guidelines historically endorsed by groups like the Endocrine Society and WPATH, argue puberty blockers and hormone therapy are individualized treatments prescribed by doctors after evaluation, not something families pursue casually. Advocates for continued access argue that cutting Medicaid and CHIP funding doesn't stop the underlying fraud allegations from being investigated on their own merits. It cuts off a treatment pathway for lower-income families who can't pay out of pocket, while wealthier families can still access the same care privately.

A policy aimed at fraud is being applied broadly enough that it also blocks a treatment some doctors and patients want, regardless of billing conduct at specific hospitals. Whether the HHS report's fraud allegations justify pulling funding for the treatment category entirely, versus prosecuting the specific billing fraud identified, remains unresolved by any court or independent audit in available reporting.

RFK Jr.'s own credibility under scrutiny

While HHS pushes its fraud and funding agenda, Kennedy is facing separate questions about transparency on vaccine-related data.

The CDC is excluding two measles deaths reported by Pennsylvania from its weekly national measles death tally. This decision came from Acting CDC Director Jim O'Neill, according to The Washington Post's Lena Sun and Rachel Roubein, citing three current and former officials who spoke on condition of anonymity, saying they feared retaliation. The Post's report does not specify why the deaths were excluded or whether CDC has offered a public explanation for the omission.

Separately, AP News reported that documents refute testimony Kennedy gave to the Senate in which he said a visit to Samoa had "nothing to do with vaccines." AP's reporting on what specifically the documents show and when the testimony and trip occurred was not detailed in available material.

What's still unresolved

CMS has not published the specific hospitals named in its billing-fraud report, and no court has ruled on whether the alleged false coding constitutes provable fraud versus a billing dispute. The CDC has not publicly explained why the two Pennsylvania measles deaths were excluded from its national tally or whether CDC leadership intends to reverse that decision. The underlying documents AP says contradict Kennedy's Senate testimony have not been made public in full, leaving open exactly what they show and how directly they conflict with his sworn statements. Congress has not announced a hearing specifically on either the measles tally exclusion or the Samoa documents as of this writing.